| dc.contributor.author | Spagnolo, F | en_US |
| dc.contributor.author | Sestak, I | en_US |
| dc.contributor.author | Howell, A | en_US |
| dc.contributor.author | Forbes, JF | en_US |
| dc.contributor.author | Cuzick, J | en_US |
| dc.date.accessioned | 2016-08-02T11:52:26Z | |
| dc.date.available | 2015-11-23 | en_US |
| dc.date.issued | 2016-01-10 | en_US |
| dc.date.submitted | 2016-03-14T10:10:36.881Z | |
| dc.identifier.issn | 0732-183X | en_US |
| dc.identifier.other | 10.1200/JCO.2015.63.4972 | |
| dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/13796 | |
| dc.description.sponsorship | Supported in part by Cancer Research UK
(C569/A5032) and the National Health and
Medical Research Council Australia
(GNT300755, GNT569213), and in part by
AstraZeneca, who also provided
anastrozole and matching placebo. This
study was sponsored by Queen Mary
University of London, London, United
Kingdom. | en_US |
| dc.format.extent | 139 - + | en_US |
| dc.language.iso | en | en_US |
| dc.relation.ispartof | JOURNAL OF CLINICAL ONCOLOGY | en_US |
| dc.title | Anastrozole-Induced Carpal Tunnel Syndrome: Results From the International Breast Cancer Intervention Study II Prevention Trial | en_US |
| dc.type | Article | |
| dc.rights.holder | 2015. American Society of Clinical Oncology | |
| dc.identifier.doi | 10.1200/JCO.2015.63.4972 | en_US |
| pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000374327000010&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
| pubs.issue | 2 | en_US |
| pubs.notes | 12 months | en_US |
| pubs.publication-status | Published | en_US |
| pubs.volume | 34 | en_US |
